Literature DB >> 8241509

Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20.

D Roulston1, R Espinosa, M Stoffel, G I Bell, M M Le Beau.   

Abstract

A deletion of the long arm of chromosome 20 [del(20q)] is a recurring abnormality in malignant myeloid disorders. The occurrence of the del(20q) in a broad spectrum of myeloid disorders suggests that the loss of genetic material on 20q could provide a proliferative advantage to myeloid cells, possibly through the loss of a tumor-suppressor gene. We have examined a series of patients with the del(20q) using fluorescence in situ hybridization (FISH) with unique sequence probes that map along the length of 20q, and have delineated a segment that is deleted in 95% of all patients examined (18 of 19). In addition, we have shown that the deletions are interstitial rather than terminal. This region of deletion extends from 20q11.2 to q12, and is flanked by the RPN2 (proximal) and D20S17 loci (distal). The SRC and ADA genes are located within the commonly deleted segment. Our findings emphasize the importance of FISH and other molecular mapping techniques in defining such a region. The delineation of a commonly deleted segment in 20q11.2-q12 will facilitate the identification of candidate tumor-suppressor genes on 20q.

Entities:  

Mesh:

Year:  1993        PMID: 8241509

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Microarray CGH analysis of hematological patients with del(20q).

Authors:  Chunxiao Wu; Jinlan Pan; Huiying Qiu; Yongquan Xue; Suning Chen; Yafang Wu; Jun zhang; Shuxiao Bai; Yong Wang; Juan Shen; Yanlei Gong
Journal:  Int J Hematol       Date:  2015-10-06       Impact factor: 2.490

2.  A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene.

Authors:  M Stoffel; M M Le Beau; R Espinosa; S F Bohlander; D Le Paslier; D Cohen; K S Xiang; N J Cox; S S Fajans; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

3.  Acute myelomonocytic leukemia with dysplastic bone marrow eosinophils showing t(5;17)(q13;q11) and a secondary chromosomal aberration, inv(16)(p13q22).

Authors:  Rika Sakai; Katsumichi Fujimaki; Etsuko Yamazaki; Hiroshi Sakamoto; Heiwa Kanamori; Ikuo Miura; Yoshiaki Ishigatsubo
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

Review 4.  Chromosome and molecular abnormalities in myelodysplastic syndromes.

Authors:  Pierre Fenaux
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

5.  Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.

Authors:  D B Zimonjic; J L Pollock; P Westervelt; N C Popescu; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.

Authors:  I Screpanti; P Musiani; D Bellavia; M Cappelletti; F B Aiello; M Maroder; L Frati; A Modesti; A Gulino; V Poli
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

Review 7.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

8.  Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines.

Authors:  Tein-Ming Yuan; Ruei-Yue Liang; Pin Ju Chueh; Show-Mei Chuang
Journal:  Oncol Lett       Date:  2015-01-27       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.